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Inclusions composed of a-synuclein (a-syn), i.e.,
Lewy bodies (LBs) and Lewy neurites (LNs), define
synucleinopathies including Parkinson’s disease
(PD) and dementia with Lewy bodies (DLB). Here,
we demonstrate that preformed fibrils generated
from full-length and truncated recombinant a-syn
enter primary neurons, probably by adsorptive-
mediated endocytosis, and promote recruitment of
soluble endogenous a-syn into insoluble PD-like
LBs and LNs. Remarkably, endogenous a-syn was
sufficient for formation of these aggregates, and
overexpression of wild-type or mutant a-syn was
not required. LN-like pathology first developed in
axons and propagated to form LB-like inclusions in
perikarya. Accumulation of pathologic a-syn led to
selective decreases in synaptic proteins, progressive
impairments in neuronal excitability and connec-
tivity, and, eventually, neuron death. Thus, our data
contribute important insights into the etiology and
pathogenesis of PD-like a-syn inclusions and their
impact on neuronal functions, and they provide
a model for discovering therapeutics targeting path-
ologic a-syn-mediated neurodegeneration.
INTRODUCTION
Aggregates of amyloid proteins characterize many neurodegen-
erative disorders including Alzheimer’s disease (AD) and Parkin-
son’s disease (PD). Formation of pathological inclusions occurs
by amultistep process including themisfolding of normal soluble
proteins and their association into higher order oligomers,
followed by their assembly into amyloid fibrils that form disease
specific inclusions (Conway et al., 2000; Uversky et al., 2001).
Recent evidence indicates that proteinaceous aggregates
composed of tau and a-synuclein (a-syn), which are character-
istic lesions of AD and PD, respectively, can induce pathology
in healthy cells (Clavaguera et al., 2009; Desplats et al., 2009;Frost et al., 2009; Guo and Lee, 2011; Luk et al., 2009). This
process is hypothesized to occur via uptake of misfolded poly-
mers, which can propagate by recruiting their endogenously
expressed counterparts, followed by their spread to induce
pathology throughout the nervous system (Aguzzi and Rajen-
dran, 2009).
Support for this concept of transmissibility comes from studies
showing that tau and a-syn pathology spread in a stereotypical
temporal and topological manner (Braak and Braak, 1991; Braak
et al., 2003). Furthermore, fetal mesencephalic grafts in the
striatum of PD patients eventually show evidence of Lewy bodies
(LB), suggesting that pathologic a-syn could be transmitted from
diseased striatal neurons to young grafted neurons (Kordower
et al., 2008a; Kordower et al., 2008b; Li et al., 2008). However,
these studies cannot determine whether the LB-like inclusions
were formed by the spread of a-syn fibrils, or whether some
other toxic effect of the neighboring diseased neurons induced
a-syn inclusions.
Although previous studies in model systems demonstrate that
exogenous amyloid fibrils can seed recruitment of intracellular
soluble proteins into inclusions, (Clavaguera et al., 2009;
Desplats et al., 2009; Frost et al., 2009; Guo and Lee, 2011;
Hansen et al.2011; Luk et al., 2009), either they employed addi-
tional factors to assist the entry of the fibrils into cells or they
utilized cell extracts containing disease proteins in which other
components that contribute to development of pathology may
exist. Also, all of these models rely on the overexpression of
human wild-type (WT) or mutant proteins. This contrasts with
the majority of neurodegenerative diseases, which are sporadic
and express normal levels of the WT proteins that are the
building blocks of the fibrillar inclusions in these disorders.
Thus, it is crucial to determine whether formation of PD-like
LBs and Lewy neurites (LNs) in cultured neurons can be facili-
tated under physiological conditions using pure WT a-syn pre-
formed fibrils (pffs) and endogenous levels of a-syn expression.
Thus, we asked whether a-syn pffs, formed from purified
recombinant human WT a-syn (a-syn-hWT), recruit endogenous
a-syn into pathologic, insoluble inclusions. We show that a-syn
pffs are internalized and induce endogenous a-syn expressed
in primary neurons to aggregate into inclusions resembling LBs
and LNs in human PD brains. LN-like accumulations are initially
detected in axons and a-syn pathology then propagates to theNeuron 72, 57–71, October 6, 2011 ª2011 Elsevier Inc. 57
Figure 1. a-syn-hWT Pffs Recruit Endogenous a-syn to Form Pathologic, Insoluble Aggregates
(A) Two weeks after pff addition, neurons were fixed with paraformaldehyde alone or paraformaldehyde with 1% Tx-100 to extract soluble proteins. In PBS-
treated neurons, a-syn localized to the presynaptic terminal and was Tx-100 soluble. Addition of a-syn pffs formed Tx-100 insoluble aggregates which recruited
a-syn away from synapses. Scale bar = 20 mm.
(B) Neurons were treated with a-syn-hWT pffs and 2 weeks later were sequentially extracted with 1% Tx-100 followed by 2%SDS. Shown are immunoblots from
2 independent sets of samples. Antibodies that either recognize the C terminus of a-syn (top) or are specific for mouse a-syn (bottom) showed that in PBS-treated
neurons, a-syn was soluble in Tx-100. a-syn-hWT pff treatment reduced soluble a-syn and increased Tx-100-insoluble a-syn. The first lane shows a -syn-hWT
pffs alone to demonstrate that the C-terminal antibody recognizes both human and mouse a-syn, and the mouse specific antibody recognizes only mouse pffs.
Furthermore, the a-syn-hWT pffs themselves are not phosphorylated.
(C) Addition of a-syn pffs increased pathologic, p-a-syn. Fixation with paraformaldehyde/Tx-100 demonstrated that the phosphorylated aggregates were
insoluble. Scale bar = 50 mm. Insert: Within the somata, aggregates appear as LB-like skein-like filaments and dense inclusions (arrow). PBS-treated neurons and
neurons from a-syn / mice did not show p-a-syn.
(D) The phosphorylated aggregates are ubiquitin positive (n = 2). Scale bar = 50 mm. See also Figure S1.
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Neuron Dysfunction in Model of a-syn Transmissioncell body where LB-like inclusions develop. Formation of these
PD-like a-syn LNs and LBs causes selective reductions in
synaptic proteins, and progressive impairments in neuronal
network function and excitability that culminate in neuron death.
RESULTS
Induction of Insoluble a-Syn Aggregates in Primary
Neurons by a-syn Pffs
To determine whether exogenous human a-syn pffs can seed
recruitment of endogenously expressed mouse a-syn into insol-
uble LB-like and LN-like fibrillar aggregates, we added a-syn pffs
generated from full-length recombinant a-syn-hWT to primary
hippocampal neurons derived from WT C57BL6 mice after
culturing them for 5–6 days in vitro (DIV). These neurons were58 Neuron 72, 57–71, October 6, 2011 ª2011 Elsevier Inc.examined 2 weeks after the addition of a-syn-hWT pffs, when
synapses are mature, and a-syn is normally localized to presyn-
aptic terminals (Murphy et al., 2000). In PBS-treated hippo-
campal neurons, endogenous mouse a-syn localized to presyn-
aptic puncta as visualized using monoclonal antibody (mAB)
Syn202,apansynucleinantibody (Giassonetal., 2000) (Figure1A,
top panels). In contrast, in a-syn-hWT pff-treated neurons, a-syn
did not localize to the presynaptic terminal (Figure 1A), but
instead formed fibrillar LN-like inclusions. To determine whether
the a-syn aggregates were detergent insoluble, PBS and a-syn-
hWT pff-treated neurons were extracted with buffer containing
1% Triton X-100 (Tx-100) during fixation. Under such conditions,
endogenous a-syn within neuronal processes in PBS-treated
neurons was soluble in Tx-100, but cells incubated with a-syn-
hWT pffs showed Tx-100-insoluble aggregates (Figure 1A).
Figure 2. Minimal a-syn Domain Necessary
for Aggregate Formation
(A) Pffs composed of full-length or indicated
truncation a-syn mutants were added to DIV5
neurons and fixed 2 weeks later. Immunofluores-
cence detected p-a-syn, Tx-100 insoluble aggre-
gates after addition of all constructs. Scale bar =
20 mm.
(B) a-syn-hWT or a-syn-mWT pffs were added to
neurons on DIV5 and 2 weeks later were either
fixed or extracted with 1% Tx-100 followed
by 2% SDS. Immunofluorescence and immuno-
blots showed that a-syn-mWT pffs induced the
appearance of phosphorylated, Tx-100-insoluble,
a-syn. Data represent two independent experi-
ments. Scale bar = 20 mm.
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Neuron Dysfunction in Model of a-syn Transmissiona-syn recruited into pathologic inclusions undergoes exten-
sive phosphorylation at Ser129 (pSer129); thus antibodies
against pSer129 selectively recognize a-syn pathology (Fujiwara
et al., 2002). Furthermore, as this modification is absent in re-
combinant a-syn pffs (Figure 1B, first lane on left, Luk et al.,
2009), the accumulation of phosphorylated a-syn (p-a-syn)
reflects an intracellular modification. PBS-treated neurons did
not show staining with 81A, a mAB specific for pSer129 (Fig-
ure 1C, Waxman and Giasson, 2008). However, neurons treated
with a-syn-hWT pffs showed intense 81A immunostaining that
was Tx-100 insoluble (Figure 1C). Pff-induced aggregates ex-
hibited morphologies ranging from small puncta to LN-like inclu-
sions of variable lengths within neurites (Figures 1C, 1D, 2, and
4–7). Within neuronal perikarya, these a-syn accumulations
resembled LBs observed in human PD brains (Figure 1C inset).
The a-syn-hWT pff-induced aggregates also occurred in primary
cultures of cortical and midbrain dopaminergic neurons (Fig-
ure S1A, available online). Furthermore, neurons generated
from other strains of mice as well as rats developed LB- and
LN-like inclusions when treated with a-syn-hWT pffs, supporting
the hypothesis that induction of a-syn pathology is a general
feature of primary rodent neurons (data not shown). P-a-syn-
positive aggregates (as detected by 81A) did not form in astro-
cytes (FigureS1B).Moreover, the appearanceofa-synpathology
required the presence of endogenous a-syn since a-syn-hWTNeuron 72, 57–7pffs did not induce any pathology in
primary neurons from a-syn / mice
(Figure 1C). Furthermore, monomeric
a-syn did not induce a-syn inclusions
(data not shown), demonstrating that
a-syn pffs alone seed the aggregates.
Immunoblot analyses were conducted
on neuron lysates sequentially extracted
with 1% Tx-100, followed by 2% SDS
(Figure 1B). In contrast to PBS-treated
neurons, those treated with a-syn-hWT
pffs for 14 days showed > 80% reduction
of a-syn in the Tx-100-soluble fraction
accompanied by a concomitant appear-
ance of a-syn in the SDS-extractable
fraction. Immunoblots of the SDS-extractable fraction also showed insoluble p-a-syn. A mouse-
specific anti-a-syn antibody did not detect a-syn-hWT pffs
(Figure 1B, first lane on left), but detected bands in the neuron
lysates similar to those labeled by the C terminus specific
a-syn antibody and mAB 81A. In addition, higher-molecular-
weight species of a-syn were detected in the SDS fraction of
all a-syn pffs-treated cultures, and likely correspond to oligo-
meric and/or ubiquitinated a-syn (Li et al., 2005; Luk et al.,
2009; Sampathu et al., 2003). Sequential extractions of primary
hippocampal neurons from a-syn / mice 14 days after addi-
tion of a-syn-hWT pffs confirmed the absence of pathological
a-syn or any other species of immunoreactive a -syn (Fig-
ure S1C). Thus, these data demonstrate that a-syn pffs induced
recruitment of soluble endogenous a-syn into insoluble, hyper-
phosphorylated a-syn aggregates.
Since a-syn is ubiquitinated in LBs and LNs, we studied a-syn
aggregates that formed 14 days after addition of a-syn-hWT pffs
and showed they were also ubiquitin positive (Figure 1D), and
colocalized with p-a-syn. Because the exogenous a-syn-hWT
pffs are not ubiquitinated or phosphorylated (Luk et al., 2009),
these posttranslational modifications must occur intracellularly
as endogenous mouse a-syn accumulates. Thus, these a-syn
aggregates share hallmark features of PD-like LNs and LBs al-
lowing us to conclude that misfolded a-syn pffs seed and recruit
normal, endogenous a-syn to form pathologic aggregates.1, October 6, 2011 ª2011 Elsevier Inc. 59
Figure 3. Ultrastructure of Aggregates
(A) Transmission EM of a-syn-hWT pff-treated
neurons showed filaments in the neuronal soma
(see box highlight).
(B) Immuno-EM of HRP-labeled p-a-syn inclu-
sions were visualized in the neuronal soma near
the nucleus.
(C) Filamentous inclusions in the neuronal soma
were labeled with nanogold particles. Insert:
higher magnification of labeled filaments.
(D) Presynaptic nanogold-labeled filaments.
(E) Neuronal process with nanogold labeled a-syn
filaments.
(F) HRP immunoreactivity showed p-a-syn in
a postsynaptic ending.
Scale Bars: 1 mm (A, B, C, and F) and 500 nm
(D and E).
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Neuron Dysfunction in Model of a-syn TransmissionPffs from the NAC Domain of a-syn Are Sufficient
to Seed Intracellular a-syn Aggregates
Previous in vitro studies have shown that recombinant a-syn
protein lacking N- or C-terminal residues, or a synthetic peptide
containing only the NAC domain (amino acid residues 61-95),
assemble into a-syn amyloid fibrils, and nucleate full-length
a-syn fibrillization (Giasson et al., 2001; Han et al., 1995; Kessler
et al., 2003; Luk et al., 2009; Murray et al., 2003; Serpell et al.,
2000). Thus, we asked whether human a-syn pffs composed of
a-syn-1-120, a-syn-1-89, a-syn-58-140, or a-syn-NAC could
seed formation of LBs and LNs in neurons. We observed that
a-syn-1-120 and a-syn-1-89 pffs induced robust accumulation
of endogenous p-a-syn aggregates that were Tx-100-insoluble
(Figure 2A; data not shown), and they are morphologically indis-
tinguishable from those formed by a-syn-hWT pffs. a-syn-58-
140 pffs also seeded formation of endogenous mouse a-syn
aggregates that were hyperphosphorylated (Figure 2A). More-60 Neuron 72, 57–71, October 6, 2011 ª2011 Elsevier Inc.over, pffs composed of only the central
hydrophobic a-syn-NAC domain also
resulted in endogenous mouse a-syn
fibrillar LB-like aggregates that were Tx-
100-insoluble. Overall, our data demon-
strate that a-syn pffs containing only the
central, hydrophobic portion of a-syn-
hWT are sufficient to seed conversion of
endogenous a-syn into pathological
aggregates.
Mice typically do not develop LBs
except in the case of transgenic lines
overexpressing mutant human a-syn.
We thus asked whether the formation of
LB-like aggregates required human
a-syn or whether they can be seeded by
a-syn pffs generated from recombinant
mouse WT a-syn (a-syn-mWT) (Touch-
man et al., 2001). Immunoblots demon-
strated that 14 days treatment of primary
neurons with a-syn-mWT pffs induced
appearance of p-a-syn in the Tx-100-
insoluble fraction (Figure 2B). Immunoflu-orescence also showed that a-syn-mWT pffs induced formation
of p-a-syn aggregates in neurites and somata. Thus, patholog-
ical PD-like a-syn aggregates can be induced by a-syn-mWT
pffs and does not require the human protein.
Ultrastructure Analysis of a-syn Aggregates
Examination of the a-syn aggregates using transmission and
immuno-EM demonstrated abundant filaments in neurons
treated with either a-syn-hWT or a-syn-1-120 pffs (Figure 3A)
for 14 days, but not PBS-treated neurons (data not shown).
Remarkably, inclusions composed of 14- to 16-nm-thick fila-
ments were seen throughout the cytoplasm, visualized by trans-
mission EM. Two different immuno-EMdetection systems, horse
radish peroxidase (HRP) and immunogold amplification, were
used to demonstrate that fibrils composed of p-a-syn are found
throughout the neuron. P-a-syn-positive fibrils were seen in the
soma (Figures 3B and 3C), adjacent to the active zone of
Figure 4. Time Dependence of Aggregate Formation
(A) Top row: a-syn-hWT pffs were added to DIV5 neurons, and fixed either 4, 7, or 10 days later. Small puncta corresponding to neuritic p-a-syn were visible
4 days after pff addition, and by 7 days, neuritic p-a-syn levels increased, and accumulations were visible in some cell bodies. Ten days after addition of pffs,
p-a-syn was seen throughout the neurites as small puncta, longer fibrous structures, and as somal accumulations. Bottom row: a-syn-hWT pffs were added to
DIV10 neurons when a-syn expression at the presynaptic terminal is higher. Pathology progressesmore quickly and are detectable at 2 days after pff addition and
aggregates in the cell bodies as early as 4 days after pff addition. Scale bar = 50 mm.
(B) Immunoblots of DIV5 neurons sequentially extracted with 1% Tx-100 and 2% SDS, 4, 7, 10, and 14 days after PBS or a-syn-hWT pff addition. Over time,
soluble a-syn was reduced with a concomitant increase in total and p-a-syn in the Tx-100-insoluble fraction.
(C and D) Double immunofluorescence for p-a-syn and the axonal marker, mouse tau (T49) (C) or the dendritic marker, MAP2 (D). P-a-syn predominantly
colocalized with tau but not MAP2 4 days after pff addition. Two weeks after pff addition, aggregates were found in axons, cell bodies and dendrites where they
colocalized with MAP2. Scale bar = 20 mm. See also Figure S2.
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Neuron Dysfunction in Model of a-syn Transmissionpresynaptic terminals (Figure 3D) and the postsynaptic terminal
(Figure 3F) and throughout processes (Figure 3E). These data
establish that the seeding and recruitment of endogenous
mouse a-syn into hyperphosphorylated insoluble, filamentous
aggregates recapitulate features of LBs and LNs in PD and other
human synucleinopathies.
Time and Concentration Dependence of a-syn
Aggregate Formation
To determine the temporal sequence of a-syn aggregate forma-
tion, a-syn-hWT pffs were added to the neurons at DIV5. P-a-syn
immunostaining was not detectable until 4 days later when small
aggregates began to appear, exclusively in the neurites, albeit at
low levels (Figure 4A, upper series). By 7 days after a-syn-hWT
pffs addition, there was an increase in a-syn pathology with
some cell bodies showing a-syn accumulations. By 10 days
post a-syn-hWT pff addition, the overall p-a-syn immunostainingwas more intense, and p-a-syn aggregates in the neurites
appeared both punctate and fibrillar resembling LNs that were
longer than the aggregates observed 4 or 7 days after a-syn-
hWT pffs addition.
The sequence of events revealed by immunofluorescence was
confirmed by biochemical experiments of sequentially extracted
neurons (Figure 4B). Four days after a-syn-hWT pffs addition,
the majority of a-syn was found in the Tx-100-soluble fraction
and showed levels similar to PBS-treated neurons. In PBS-
treated control neurons, there was an increase in a-syn levels
by DIV10 as demonstrated previously (Murphy et al., 2000).
In contrast, 7–10 days after a-syn-hWT pff treatment, soluble
levels of a-syn were reduced, accompanied by a concomitant
increase of a-syn into the Tx-100-insoluble fraction. Thus, these
data indicate that a-syn-hWT pff-induced recruitment of mouse
a-syn into the insoluble fraction with a lag phase of a few days
followed by a progressive increase in insoluble p-a-syn.Neuron 72, 57–71, October 6, 2011 ª2011 Elsevier Inc. 61
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terminals increase as primary neurons mature, (Murphy et al.,
2000; Figure 4B, day 4 PBS versus day 10 PBS), we asked
whether adding pffs to mature neurons would enhance the rate
of aggregation. When a-syn-hWT pffs were added to DIV 10
neurons, aggregates were visible in neurites 2 days later (Fig-
ure 4A, lower series), in contrast to 4 days required after addition
of pffs to DIV5 neurons. By 4 days after a-syn-hWT pff treatment
of DIV10 neurons, small punctate aggregates were detected
throughout the neurites and some somata also showed accumu-
lations, again unlike 4 days after adding pffs to DIV5 neurons in
which a-syn pathology was exclusively in neurites. Seven days
after a-syn-hWT pff treatment of DIV10 neurons, the pathology
was extensive, similar to 10 days a-syn-hWT pff treatment of
DIV5 neurons (Figure 4A). Thus, a-syn aggregates develop faster
in mature neurons, consistent with in vitro studies demonstrating
that the rate of fibril formation positively correlates with a-syn
concentrations (Wood et al., 1999).
We next examined whether the amount of a-syn pathology
correlated with the amount of fibrils added. We found progres-
sive decreases in the amount of somatic and neuritic pathology
correlated with 10-fold serial dilutions of a-syn-hWT pffs added
(in ng/mL: 100, 10, 1, 0.1; Figure S2). Thus, the rate and extent
of pathology depends on the amount of a-syn pffs, and that small
quantities of a-syn pffs are sufficient to seed a-syn aggregate
formation, consistent with in vitro studies showing that the rate
of seeded assembly depends on the initial concentrations of
a-syn pffs (Wood et al., 1999).
Initial Formation of a-syn Pathology within Axons
Because a-syn normally localizes to the presynaptic terminal
and since a-syn puncta initially appeared in neurites, we hypoth-
esized that a-syn-hWT pffs recruited presynaptic a-syn into
insoluble aggregates that then propagate from the axons to
the cell bodies. To demonstrate that the pathology initiated in
axons, we conducted double labeling immunofluorescence
studies using a mAB specific for mouse tau (T49, an axonal
marker) and 81A. P-a-syn aggregates colocalized predominately
with tau 4 days after pff addition (Figure 4C; upper panel), but not
with the dendritic marker, microtubule associated protein 2
(MAP2) (Figure 4D, upper panel), indicating that a-syn accumu-
lations were initiated in axons. However, by 14 days, when
more accumulations appeared in the somata, the a-syn aggre-
gates were seen in axons (Figure 4C, lower panel), in cell bodies,
and proximal dendrites where they colocalized with MAP2 (Fig-
ure 4D, lower panel). Thus, a-syn is recruited away from the
presynaptic terminal with subsequent spread via axons to other
parts of the polarized neuron.
Enhanced Endocytosis of a-syn Pffs Increases
the Extent of Pathology
To determine whether a-syn-hWT pffs can gain access to the
cytoplasm to seed recruitment of endogenous a-syn, we per-
formed two-stage immunofluorescence using antibodies that
recognize only human a-syn pffs. Live neurons were labeled at
4C with mAB Syn204 followed by fixation, permeabilization,
and incubation with the antibody, LB509 (Giasson et al., 2000).
Thus, mAB Syn204 labeled only extracellular hWT pffs whereas62 Neuron 72, 57–71, October 6, 2011 ª2011 Elsevier Inc.LB509 recognized both extracellular and intracellular hWT pffs.
Many a-syn-hWT pffs remained outside the neuron and were
double-labeled with both mAB Syn204 and LB509 (yellow in
the merged image, Figure 5A). However, significant amounts of
small puncta labeled exclusively with LB509 (green, arrowheads
highlight examples in the merged image), suggesting that a-syn-
hWT pffs gain entry inside the neuron, as demonstrated previ-
ously for both a-syn and tau amyloid fibrils (Luk et al., 2009;
Guo and Lee, 2011). Furthermore, double-labeling immunofluo-
rescence in fixed, permeabilized neurons with mAB 81A and
mAB Syn204 showed p-a-syn accumulating near seeds of
a-syn-hWT pffs (Figure 5B). A 3D view constructed from serial
confocal images demonstrated colocalization between a-syn-
hWT pffs (Syn204) and p-a-syn (81A) in the XY, XZ, and YZ
planes (Figure 5C), further confirming that intracellular pffs
seed recruitment of endogenous a-syn. Since p-a-syn is exclu-
sively intracellular, our data indicate that pffs enter the cytoplasm
where they initiate accumulation of pathologic p-a-syn.
To begin assessing the mechanism by which pffs gain entry to
the cytoplasm, we treated neurons with a-syn-hWT pffs in the
presence of wheat germ agglutinin (WGA) which binds N-acetyl-
glucosamine (GlcNAC) and sialic acids at the cell surface and
induces adsorptive-mediated endocytosis (Banks et al., 1998;
Broadwell et al., 1988; Gonatas and Avrameas, 1973). To deter-
mine the effects of WGA on formation of a-syn aggregates,
neurons were treated at DIV5 and fixed for immunofluorescence
4 days later. When incubated with a-syn-hWT pffs alone, few
p-a-syn puncta were visible in a subset of neurites (Figure 5D).
Coincubation of pffs with WGA dose-dependently increased
the extent of p-a-syn pathology. In addition to small puncta,
longer, continuous p-a-syn filaments were visible, and a-syn
pathology was present in the cell body, particularly with
5 mg/mL of WGA treatment. Furthermore, the addition of 0.1 M
GlcNAc, a competitive inhibitor of WGA, reduced the effects of
WGA on a-syn pff-induced aggregate formation. Immunoblots
of sequentially extracted neurons confirm that WGA-mediated
endocytosis enhances formation of pathologic a-syn. Four
days after treatment with a-syn-hWT pffs alone, the majority of
a-syn remained in the Tx-100 extractable fraction, whereas
coincubation of a-syn-hWT pffs with 5 mg/mL of WGA increased
the amount of Tx-100 insoluble a-syn. Taken together, our find-
ings indicate that a-syn pffs gain access to the neuronal cyto-
plasm by adsorptive endocytosis.
Intracellular Propagation of Pathologic a-syn
To determine whether direct addition of a-syn pffs to either
neurites or somata leads to propagation of pathologic a-syn
aggregates throughout the neuron, we utilized microfluidic
culture devices that isolate the neuronal processes from the
cell bodies via a series of interconnected microgrooves (Taylor
et al., 2005). C-terminally myc-tagged a-syn-1-120 pffs added
to the neuritic chamber (Figure 6A) resulted in p-a-syn-positive
aggregates within axons and cell bodies (Figure 6B and 6C).
Aggregates were morphologically identical to those seen in
primary neurons directly exposed to pffs, and they were also
insoluble in Tx-100 (Figure 6D). Anti-myc immunostaining sug-
gested that pffs did not enter into the somal compartment (Fig-
ure 6C and 6D) or microgrooves. Thus, these data indicate that
Figure 5. a-syn-hWT Pffs Are Internalized into Neurons
(A) Live neurons were incubated with mAB Syn204 (red) to label extracellular a-syn-hWT pffs, followed by fixation, permeabilization, and incubation with LB509
(green) to label both intracellular and extracellular a-syn-hWT pffs. Extracellular a-syn-hWT pffs are visualized as yellow in the merged image. Arrowheads
highlight examples of internal a-syn-hWT pffs (green). Scale bar = 10 mm.
(B) Fixed and permeabilized neurons were double labeled with mABs 81A (green) to detect p-a-syn and Syn 204 (red) to detect a-syn-hWT pffs. P-a-syn can be
visualized accumulating from seeds of a-syn-hWT pffs.
(C) a-syn-hWT pffs were added to DIV5 neurons and fixed 14 days later, and immunofluorescence was performed to label extracellular a-syn-hWT pffs (red) and
p-a-syn (green). A z-stack of confocal images shows that puncta corresponding to a-syn-hWT pffs colocalized with p-a-syn within a neurite, suggesting that
pathologic p-a-syn grows from intracellular pffs.
(D) DIV5 neurons were treated with either a-syn-hWT pffs alone or pffs with 1 mg/mL or 5 mg/mL of WGA. To inhibit WGA endocytosis, neurons were preincubated
with 0.1 M GlcNAC followed by incubation with pffs, GlcNAC, and 5 mg/mL of WGA. Neurons were fixed 4 days later. Immunoblots and immunofluorescence
showed that WGA dose-dependently increased the extent of insoluble p-a-syn.
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propagated retrogradely to the cell bodies.
We also exposed neuronal somata that were isolated from
neurites in the microfluidic devices to a-syn-1-120-myc pffs
and assessed the extent of a-syn pathology in the processes(Figure 6E). As expected, neurons treated with a-syn-1-120-
myc pffs formed somatic p-a-syn pathology (Figure 6F).
P-a-syn aggregates were also detected in axons that extended
through the microgrooves into the neurite chamber, as revealed
by colabeling with tau (Figure 6F). Again, a-syn aggregatesNeuron 72, 57–71, October 6, 2011 ª2011 Elsevier Inc. 63
Figure 6. Intracellular Propagation of Pathologic a-syn Aggregates
(A) Hippocampal neurons were grown in microfluidic chambers interconnected by channels accessible only to neuronal processes. a-syn-1-120-myc pffs were
added to the compartment containing exclusively neurites of DIV 5 neurons.
(B) Neurons stainedwith SNL-4 (total syn) 7 days after treatment with a-syn pffs showing the distribution of neurites, somata, and exogenous pffs which appear as
large puncta in the neuritic compartment. P-a-syn is foundwithin themicrochannels aswell as cell bodies in the somatic chamber, indicating propagation of a-syn
pathology from neurites toward the somata. Inset shows high power images of the somatic (top) and neuritic (bottom) compartments.
(C and D) a-syn-1-120-myc pff-treated neurons were double-stained using anti-myc and syn202 (Syn) before (C) and after extraction with Tx-100 (D),
demonstrating the presence of insoluble p-a-syn within neurons and processes. myc-positive pffs were confined to the neuritic compartment.
(E) a-syn-1-120-myc pffs were added to the somal-containing compartment of DIV5 neurons.
(F) Neurons immunostained for tau and p-a-syn showing pathology extending within axonal processes from the somal compartment into the neuritic
compartment.
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cence using the anti-myc antibody demonstrated that a-syn-1-
120-myc pffs were confined to the somatic compartment (Fig-
ures 6G and 6H). Thus, we conclude that pathologic p-a-syn
aggregates also propagate in the anterograde direction.
Formation of Aggregates Leads to Neuron Loss
and Diminished Levels of Select Synaptic Proteins
a-syn resides predominantly at the presynaptic terminal and
previous reports indicate that it acts as a cochaperone, in con-
cert with another chaperone, cysteine-string protein a (CSPa),
to maintain SNARE complex formation by binding to VAMP2/
synaptobrevin 2 (Burre´ et al., 2010; Chandra et al., 2005;
Greten-Harrison et al., 2010). Thus, we examined the conse-
quences of recruitment of a-syn into insoluble aggregates on
synaptic protein distribution and expression. In PBS-treated
control neurons, a-syn colocalized with VAMP2 at the presyn-
aptic terminal. Addition of a-syn-hWT pffs led to a depletion
of a-syn from the presynaptic terminal such that it showed
minimal colocalization with presynaptic VAMP2 (Figure 7A). To
further investigate the molecular consequences of recruitment
of endogenous a-syn into insoluble aggregates, we examined
additional synaptic proteins that could be impacted by the path-
ological sequestration of a-syn into aggregates and away from
the presynaptic terminal. Although b-synuclein (b-syn), another
member of the same family of neuronal proteins as a-syn, but
lacking the NAC domain, colocalized with a-syn at presynaptic
terminals in control neurons (Murphy et al., 2000), a-syn-hWT
pff addition did not change the presynaptic localization of
b-syn (Figure S3). Furthermore, Tx-100 extraction showed that,
unlike pathological a-syn, which localized to detergent insoluble
aggregates, b-syn remained soluble (Figure S3). Immunoblot
analyses showed that endogenous b-syn was Tx-100 soluble
14 days after adding a-syn pffs (Figure 7B) and protein levels
in pff-treated neurons were not statistically significantly different
from PBS-treated neurons. Thus, like LBs in PD brains, the
aggregates that developed in primary neurons are composed
of insoluble a-syn, but not b-syn (Spillantini et al., 1998). Impor-
tantly, this is consistent with the selective recruitment of a-syn by
pffs as opposed to the indiscriminate disruption of adjacent
presynaptic components.
Nonetheless, we were able to detect statistically significant
reductions in a subpopulation of synaptic proteins two weeks
after the addition of a-syn-hWT pffs, including the synaptic
vesicle-associated SNARE proteins, Snap25 and VAMP2, as
well as soluble proteins that participate in SNARE complex
assembly or the exo-endocytic synaptic vesicle cycle such as
CSPa, and synapsin II (Figure 7B). Levels of other synaptic
proteins showed slight, but not statistically significant reduc-
tions. Changes were not observed in GAPDH, the plasma
membrane-associated SNARE protein, syntaxin 1, or the trans-
membrane synaptic protein synaptophysin.
Since loss of synaptic proteins may correlate with neurode-
generation, we asked whether the accumulation of a-syn aggre-(G and H) a-syn-1-120-myc pff-treated neurons double-stained using anti-Myc an
is Tx-100-insoluble. a-syn-1-120-myc pffs remained confined to the somal co
propagation from the perikarya to the neurites. Scale bar = 50 mm in (B) and 40 mgates leads to neuron loss. NeuN-positive neuronswere counted
in cultures treated with PBS or a-syn-hWT pffs 4, 7, or 14 days
after a-syn pff addition. While there was a slight but not statisti-
cally significant decrease in number of neurons 7 days after
a-syn-hWT pff treatment, by 14 days after pff treatment, there
was a significant 40% decrease in neurons relative to PBS
controls (Figure 6C). Cell death did not occur in a-syn-hWT
pff-treated neurons derived from a-syn / mice, demon-
strating that intracellular aggregates, rather than the mere addi-
tion of exogenous pffs, caused neuron death. Finally, using
ethidium homodimer to detect dead cells and Hoechst 33342
to detect total cells, we demonstrated a 68% increase in cell
death 14 days after pff-treatment (56.6%) versus PBS-treated
(33.6%) neurons.
Disruption in Network Activity Matches the Progression
of a-syn Pathology
The decreased levels of synaptic proteins suggest impairment in
neural network activity following accumulation of a-syn inclu-
sions. Calcium imaging of hippocampal neurons loaded with
the calcium-sensitive fluorescent dye, Fluo-4 AM, was per-
formed to investigate the effect of a-syn aggregates on the
activity patterns of the in vitro neural network established by
these cultured neurons. The spontaneous activity of neurons
treated with PBS was characterized by flickering events, inter-
mixed with network-wide bursts when nearly all the neurons
were simultaneously firing as reflected by a high synchronization
index (Figure 8B). In contrast, neurons treated with a-syn-hWT
pffs showed a significant decrease in synchronized activity as
early as 4 days after treatment. At this time point, low levels of
a-syn aggregates were visualized exclusively in axons by immu-
nofluorescence microscopy, and no pathological a-syn was
detected biochemically (Figures 4A and 4B). Yet, this was
sufficient to impair coordinated network activity. This reduction
in synchronized activity persisted at 7, 10, and 14 days after
a-syn-hWT pff treatment (Figure 8B). In contrast, a-syn-hWT
pff-treated neurons from a-syn / mice showed no impair-
ments in the synchronization index, indicating that these effects
are selective for neurons harboring a-syn aggregates and do
not result from exogenously added pffs.
We next determined whether the progressive recruitment of
a-syn into pathologic aggregates correlated with changes in
the excitatory tone of the network. First, synchronous oscilla-
tions were forced using the GABA(A) antagonist, bicuculline, to
abolish inhibitory input, followed by increasing doses of the
AMPA receptor antagonist, NBQX, until synchronous oscilla-
tions stopped (Figure 8C). The final concentration of NBQX
required to impair activity within the excitatory network deter-
mined the excitatory tone. No significant changes in excitatory
tone was detected in cultures 4 or 7 days after a-syn-hWT pff
treatment but by 10 and 14 days after treatment, when
increasing accumulation of neuritic and perikaryal pathology
was observed, there were significant reductions in excitatory
tone (Figure 8D), reflecting compromised synaptic activity.d Syn202 before (G) and after extraction with Tx-100 (H). a-syn within the axons
mpartment and thus p-a-syn within the neuritic compartment resulted from
m in (C, D, and F–H).
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Figure 7. Effects of Aggregate Formation on Neuronal Density and Expression of Synaptic Proteins
(A) Neurons were fixed 2 weeks after treatment with PBS or a-syn-hWT pffs. Formation of a-syn aggregates caused recruitment of a-syn away from the
presynaptic terminal such that it no longer colocalized with VAMP2.
(B) Immunoblots for the indicated synaptic proteins from neurons 2 weeks after treatment with PBS or a-syn-hWT pffs and sequentially extracted with buffer
containing 1% Tx-100 followed by 2% SDS. Equal amounts of protein were loaded in each lane. Band intensities were quantified and expressed as average
percent change (±SEM) in protein levels from pff-treated neurons relative to PBS-treated neurons. *indicates p < 0.05, ** indicates p < 0.01. GAPDH, n = 4; bsyn,
n = 3; CSPa, n = 7; complexin, n = 4, Synapsin I, n = 3; Synapsin II, n = 8; Snap25, n = 8; VAMP2, n = 6; Syntaxin I, n = 7; Synaptophysin, n = 7; Dynamin I, n = 4;
GlurI, n = 4; PSD95, n = 5.
(C) Neurons were fixed 4 (n = 3), 7 (n = 2), or 14 days (n = 5) after addition of a-syn-hWT pffs or PBS and immunofluorescence was performed using NeuN to label
neuronal nuclei. Numbers of nuclei were counted in cultures from WT neurons and a-syn / neurons (n = 2). There was an approximately 40% decrease in cell
number in a-syn-hWT pff-treated, WT, but not a-syn / neurons relative to PBS-treated controls only after 14 days of pff treatment. See also Figure S3.
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in excitatory tone at 10 and 14 days after pff treatment, confirm-
ing that the effects result from the accumulation of endogenous
a-syn aggregates.
Since spatiotemporal patterns of activity are shaped by the
underlying connectivity architecture and the relative balance
of excitation and inhibition, we used network activity patterns
to determine the functional connectivity in PBS and a-syn-
hWT pff-treated neurons. As neurons matured in vitro, the
number of functional connections increased and eventually
plateaued (Figure 8F). The timeframe for this correlated well
with neurite sprouting and synapse stabilization based on pre-
vious studies of developing connections in vitro (Soriano66 Neuron 72, 57–71, October 6, 2011 ª2011 Elsevier Inc.et al., 2008). However, in a-syn-hWT pff-treated WT, but not
a-syn / neurons, the maturation of functional connections
never reached the level achieved in PBS-treated cultures,
as a significant reduction was observed 10 days after a-syn-
hWT pff treatment (Figure 8F). This functional connectivity
was severely compromised 14 days after treatment and the
network consisted of just a few sparse connections at this
time point (Figures 8E and 8F). In summary, the formation of
insoluble aggregates of endogenous a-syn results in early
disruption in coordinated network activity. Later, as more
a-syn inclusions develop and propagate throughout the neuron,
excitatory tone is decreased and functional connectivity is
greatly reduced.
Figure 8. Effect of Aggregate Formation on Neural Network Activity
Calcium imaging on hippocampal neurons loaded with the calcium-sensitive fluorescent dye, Fluo4-AM, was performed.
(A) PBS-treated WT neurons showed flickering events and simultaneous bursting. The spontaneous activity in a-syn-hWT pff-treated WT neurons showed
reduced coordination and frequency of oscillations.
(B) The level of coordinated spontaneous activity was quantified as the synchronization index. a-syn-hWTpff-treated neurons (red) showed a significant decrease
in synchronicity by day 4, relative to PBS-treated neurons (blue) and the deficit continued for longer treatment duration. Primary neurons from a-syn / mice
treated with a-syn-hWT pffs (purple) did not show reductions in the synchronization index relative to PBS-treated neurons (green).
(C) Excitatory tone in the network was determined by recording spontaneous activity and then by forcing synchronous oscillations via network disinhibition with
bicuculline. Incremental concentrations of NBQX were added until coordinated activity stopped and the excitatory tone was reported as [NBQX]/Kd.
(D) Excitatory tone in PBS (blue) and a-syn-hWT pff (red)-treated neurons, showed significant decreases by 10 as well as 14 days after pff treatment. Addition of
a-syn-hWT pffs to a-syn / neurons did not affect excitatory tone.
(E) Functional network connectivity, derived from the rasters in (A), is depicted as nodes (neurons) of varying sizes, where the size of a given node is scaled to
reflect the total number of connections to that particular node.
(F) The average number of connections per neuron was determined from functional connectivity map. Compared to PBS, a-syn-hWT pff-treated neurons had
fewer numbers of functional connections. Connectivity of a-syn-hWT pff-treated a-syn / neurons were similar to PBS-treated neurons. PBS-treated: day 4,
n = 9; day 7, n = 11; day 10, n = 10; day 14, n = 9. PFF-treated: day 4, n = 9; day 7, n = 12; day 10, n = 11; day 14, n = 9.
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Here we demonstrate that seeds derived from a-syn amyloid
fibrils generated with pure recombinant full-length and truncatedhuman WT a-syn, when directly added to mouse primary hippo-
campal neurons, are internalized and induce the recruitment of
endogenous soluble a-syn into insoluble pathologic LB-like
and LN-like a-syn aggregates resembling those found in humanNeuron 72, 57–71, October 6, 2011 ª2011 Elsevier Inc. 67
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aggregates in cultured mouse neurons to LBs and LNs found
in PD brains is striking because they are found in perikarya
and extensively in neurites, insoluble, filamentous by EM and
immuno-EM, hyperphosphorylated, and ubiquitinated, and
they exclude b-syn (Baba et al., 1998; Duda et al., 2000; Fujiwara
et al., 2002; Spillantini et al., 1998). Notably, these aggregates
initially formed within axons, sequestering endogenous a-syn
away from presynaptic terminals, followed by propagation into
the somata. Over time, formation of these a-syn aggregates
leads to selective alterations in synaptic proteins, compromises
neuronal excitability and connectivity, and culminates in neuron
death. Thus, we have developed a neuronal culture model of
PD-like a-syn inclusion formation that allows for the dissection
of the mechanisms leading to the formation of LBs and LNs, as
well as for studies of the impact of these inclusions on the func-
tion and viability of affected neurons. Moreover, since the
majority of PD and DLB cases are sporadic and are not caused
by mutations or overexpression of a-syn, our neuronal model
system provides a means to study the pathogenesis of a-syn
in sporadic PD, as well as other a-synucleinopathies.
We show that a-syn pffs made from pure, recombinant protein
are highly potent in the recruitment of the endogenously
expressed protein into LB-like and LN-like a-syn pathology, in
contrast to previous studies that have relied on experimental
manipulations such as protein overexpression of WT andmutant
proteins, and/or extrinsic factors to introduce pffs into cells
(Clavaguera et al., 2009; Frost et al., 2009; Guo and Lee, 2011;
Luk et al., 2009). These results thus provide support that a-syn
amyloid fibrils alone are sufficient to seed and drive a-syn
pathology in healthy neurons. Indeed, our findings can plausibly
account for the observation that fetal grafts of embryonic
neurons in diseased PD brains develop LBs over time, since
this could be caused by the direct uptake of fibrillar a-syn seeds
from diseased neurons in the brains of these patients (Kordower
et al., 2008a, 2008b; Li et al., 2008). Furthermore, our data also
suggest a pathological mechanism whereby misfolded a-syn
species can amplify and propagate in the CNS. Because it is
possible that both mature a-syn fibrils and oligomers (Waxman
and Giasson, 2009; Winner et al., 2011) induce a-syn pathology,
additional studies are needed to determine the nature of the
pathogenic species capable of producing these changes. In
addition, although the source of the nidus that initiates a-syn
misfolding in PD and related diseases remains enigmatic (e.g.,
whether it arises from genetic mutations or environmental
toxins), we provide provocative evidence that small amounts of
misfolded a-syn pffs can trigger the spread of a-syn pathology
throughout the entire neuron.
Two-stage immunofluorescence to distinguish extracellular
from internal pffs and confocal microscopy to demonstrate
colocalization between pffs and p-a-syn suggest that small
amounts of a-syn pffs gain access to the neuronal cytoplasm
where they can seed a-syn misfolding and accumulation into
hyperphosphorylated a-syn inclusions. Coincubation of a-syn
pffs with WGA enhances the extent of pathology, implicating
adsorptive-mediated endocytosis as a potential mechanism by
which pffs gain entry to the neuron. While the mechanisms by
which a-syn pffs are internalized and released into the cytosol68 Neuron 72, 57–71, October 6, 2011 ª2011 Elsevier Inc.require further investigation, it is apparent that they efficiently
induce pathology. High concentrations of a-syn are present
in presynaptic terminals, where it associates with vesicular
membranes and undergoes rapid exchange between bound
and unbound states (Fortin et al., 2010). Thus, high local concen-
trations of presynaptic a-syn, coupled with its dynamic charac-
teristics, may facilitate recruitment of endogenous mouse
a-syn by the internalized a-syn pffs to form insoluble fibrils.
We show that formation of a-syn pathology is more efficient in
mature neurons with higher levels of a-syn expression at presyn-
aptic terminals. Interestingly, levels of a-syn increase with age
(Chu and Kordower, 2007) and a-syn gene duplication and
triplication can lead to PD (Singleton et al., 2003). Thus, aging-
dependent or gene dosage-dependent increased expression
of a-syn may render these neurons more susceptible to a-syn
inclusion formation after internalization of a-syn seeds. Future
studies will determine whether PD-associated mutations in
a-syn or overexpression of a-syn caused by gene duplication
or triplication enhance the kinetics of a-syn aggregate formation,
but it is clear from our data that normal neuronal expression of
a-syn is sufficient for seeding of a-syn pathology after exposing
these neurons to a-syn pffs.
Our model has allowed us to determine some of the conse-
quences of potential a-syn dysfunction resulting from its recruit-
ment into inclusions, which include reduced levels of synaptic
proteins, impaired neuronal function and eventual death of
affected neurons. Diminished neuronal synchronization begins
early after pff addition when small aggregates are visible only
in axons, suggesting that even a minor burden of a-syn
pathology can have amajor impact on the coordinated activation
of neuronal ensembles. By 10 days and 14 days after pff treat-
ment, when pathology is extensive, neuronal excitability and
connectivity is substantially reduced, which may be accounted
for by the reductions in presynaptic proteins. Alterations in the
expression and localization of these proteins occurs upon abla-
tion of all three synuclein family members or overexpression of
a-syn (Burre´ et al., 2010; Greten-Harrison et al., 2010; Nemani
et al., 2010). Sequestration of a-syn away from the presynaptic
terminal into insoluble inclusions may impair the homeostasis
of presynaptic proteins and consequently, synaptic vesicle
exocytosis, as suggested by previous studies demonstrating
that a-syn, in cooperation with CSPa, may act as a chaperone
to maintain presynaptic SNARE complex assembly (Burre´
et al., 2010; Chandra et al., 2005). Over time, disruptions in the
synaptic vesicle exo-endocytic cyclemay contribute to neurode-
generation found in PD and DLB.
Conclusions
For enigmatic reasons, LB pathology in sporadic PD disease
progresses in a temporally and topologically sequential manner,
and it has been suggested that the pathology is transmitted from
neuron-to-neuron, presumably by spreading along axons (Braak
and Braak,1991; Braak et al., 2003). Our findings suggest that
LB/LN pathology can be induced by misfolded a-syn and is
propagated within neurons. Mounting evidence suggests that
propagation of protein aggregates may be a unifying mechanism
of disease progression in AD and PD (Clavaguera et al., 2009;
Desplats et al., 2009; Frost et al., 2009; Guo and Lee, 2011;
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directly induce endogenous a-syn to form pathological aggre-
gates that are spread throughout the neuron and accumulate
as LB-like and LN-like inclusions support this unifying mecha-
nism of disease progression and therefore have important impli-
cations for understanding the onset and progression as well as
etiopathogenesis of sporadic PD and other neurodegenerative
disorders. Thus, our findings open up new avenues of research
into understanding mechanisms underlying the development
LB and LN pathology, their impact on neuronal function, and
discovering therapies for PD and other a-synucleinopathies.
EXPERIMENTAL PROCEDURES
Primary Neuronal Cultures
Primary neuronal cultures were prepared from E16-E18 C57BL/6 mouse
brains (Charles River, Wilmington, MA) and a-syn/ mice (Abeliovich,
et al., 2000). All procedures were performed according to the NIH Guide
for the Care and Use of Experimental Animals and were approved by the
University of Pennsylvania Institutional Animal Care and Use Committee.
Dissociated hippocampal neurons were plated onto poly-D-lysine coated
coverslips (Carolina Biological Supply, Burlington, NC) or dishes at 20,000-
40,000 cells/cm2 or 70-100,000 cells/cm2, respectively. Most experiments
were performed at 19 DIV.
Preparation and Fibril Transduction
Recombinant full-length and truncated a-syn with and without a C-terminal
myc-tag, were purified as previously described (Giasson et al., 2001). a-syn
pffs were generated by incubating purified a-syn (5 mg/mL in PBS) at 37C
with constant agitation for 5 days, followed by aliquoting and storage
at 80C. The presence of amyloid was confirmed using Thioflavin T fluoro-
metry. Fibrils of a-syn synthetic NAC peptide (amino acids 61-95) (Biotech-
nology Resource Center, Yale University) were generated as described
(Giasson et al., 2001). Pffs were diluted in PBS at 0.1mg/mL, sonicated several
times, and diluted in neuronal media. For a 24-well tray, 1 mg/mL of pffs were
added, and 5 mg/mL of a-syn pffs were added to a 60 cm dish. For WGA
experiments, a-syn pffs were incubated with 1 mg/mL or 5 mg/mL WGA or pre-
incubated for 1 hr (h) with 0.1 M GlcNAC followed by incubation with media
containing a-syn pffs, GlcNAC, and WGA.
Indirect Immunofluorescence
Neurons were fixed with 4% paraformaldehyde/4% sucrose in PBS followed
by permeabilization with 0.1% Triton X-100. To determine whether the patho-
logic a-syn aggregates were detergent insoluble, neurons were fixed with 4%
paraformaldehyde, 4% sucrose, and 1% Tx-100 (Luk et al., 2009). Neurons
were incubated in primary antibodies (Table S1) followed by Alex fluor-
conjugated secondary antibodies (Invitrogen; Carlsbad, CA). Two-stage
immunofluorescence was performed as described previously (Guo and Lee,
2011) to distinguish between extracellular and intracellular a-syn-hWT pffs
using mABs LB509 and Syn204. Unless otherwise stated in the figure legends,
all experiments were performed a minimum of 3–10 times.
EM and Immuno-EM
Primary hippocampal neurons were fixed 14 days after addition of pffs.
Neurons for transmission EMwere fixed in 2.5% glutaraldehyde in 0.1M caco-
dylate buffer, pH 7.4, and postfixed for 1 hr in 1% OsO4 and 1.5% potassium
ferrocyanide in 0.05 M cacodylate buffer. For immuno-EM, neurons were fixed
in periodate-lysine-paraformaldehyde and permeabilized with 0.05% saponin
in PBS with 2% fish gelatin (PBS-FG) and 0.05% thimerosal followed by incu-
bation in mAB 81A. Neurons were then incubated in biotinylated horse anti-
mouse IgG (Vector Laboratories, Burlingame, CA) followed by Avidin-Biotin
Complex Elite (Vector Laboratories, Burlingame, CA) and postfixed for
15 min in 1.5% glutaraldehyde in 0.1 M cacodylate buffer with 5% sucrose
and developed in DAB. For immunogold labeling, neurons were fixed and incu-
bated in mAB 81A as for HRP immuno-EM followed by incubation with goatanti-mouse IgG coupled to nanogold (Nanoprobes, Yaphank, NY). The
nanogold labeled neurons were postfixed and gold toned with 0.05% gold
chloride.
Sequential Extraction and Immunoblot Analyses
Neurons were scraped into 1% Tx-100 in Tris-buffered saline (TBS) (50 mM
Tris, 150 mM NaCl, pH 7.4) and protease and phosphatase inhibitor cocktail
at 4C. Lysates were sonicated and centrifuged at 100,000 3 g for 30 min.
The pellet was washed and suspended in 2% SDS in TBS. Samples were
separated by SDS-PAGE and immunoblotting was performed using primary
antibodies described in Table S1. All immunoblots were performed aminimum
of 3–8 times.
Microfluidic Chambers
Microfluidic neuronal culture devices with 2 somal compartments connected
by a series of microgrooveswere obtained from XonaMicrofluidics (Temecula,
CA). Glass coverslips (Corning Inc.) were coated with poly-d-lysine and affixed
to neuronal devices as per the manufacturer’s instructions. A total of 10,000
dissociated hippocampal neurons were plated. A 50 ml difference in media
volume was maintained between the two compartments to regulate the
direction of flow. a-syn 1-120-myc pffs (2 mg) were added to the neuritic
compartment (retrograde experiments) or the somal compartment (antero-
grade experiments) and were fixed 7–12 days later. The retrograde experi-
ments were repeated 4 times and anterograde experiments repeated 3 times,
each in triplicates.
Calcium Imaging and Network Analyses
Hippocampal neurons were plated on MatTek dishes at 300,000 cells/dish
and treated with PBS or 5 mg/mL a-syn-hWT pffs. Neurons were loaded with
Fluo4-AM (1 mM, Invitrogen,Carlsbad, CA). Spontaneous calcium activity
from 200 neurons was recorded for 5 min, at 10Hz acquisition. Synchronous
oscillations were forced with bicuculline (100 mM, Tocris) and increasing doses
of the AMPAR antagonist, NBQX. When synchronous oscillations stopped,
this final concentration of NBQX was used as an indication of excitatory
tone (Breskin et al., 2006). Custom-coded MATLAB scripts were used to
analyze the images.
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